5 Einträge gefunden

1. Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells.

   1. Atanackovic, Djordje
   2. Hildebrandt, York
   3. Jadczak, Adam
   4. Cao, Yanran
   5. Luetkens, Tim
   6. Meyer, Sabrina
   7. Kobold, Sebastian

   2009 - Forschungsinformationssystem des UKE - frei zugänglich
2. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

   1. Lioznov, Michael
   2. El-Cheikh, J
   3. Hoffmann, Friedericke
   4. Hildebrandt, York
   5. Ayuketang Ayuk, Francis
   6. Wolschke, Christine
   7. Atanackovic, Djordje

   2009 - Forschungsinformationssystem des UKE
3. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.

   1. Kröger, Nicolaus
   2. Badbaran, Anita
   3. Lioznov, Michael
   4. Schwartz, Sabine
   5. Zeschke, Silke
   6. Hildebrandt, York
   7. Ayuketang Ayuk, Francis

   2009 - Forschungsinformationssystem des UKE
4. Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?

   1. Kobold, Sebastian
   2. Hegewisch-Becker, Susanna
   3. Oechsle, Karin
   4. Jordan, Karin
   5. Bokemeyer, Carsten
   6. Atanackovic, Djordje

   2009 - Forschungsinformationssystem des UKE
5. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.

   1. Atanackovic, Djordje
   2. Luetkens, Tim
   3. Hildebrandt, York
   4. Arfsten, Julia
   5. Bartels, Katrin
   6. Horn, Christiane
   7. Stahl, Tanja

   2009 - Forschungsinformationssystem des UKE